what's a glp 1 drug GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Medications Show Promise as

TGA-approved for weight management (BMI 30, or 27 with comorbidities) but not yet PBS-funded

The trial exhibited a favorable safety profile with mostly mild to moderate gastrointestinal adverse events, including diarrhea (38% versus 19% in placebo), constipation (27% versus none), and appetite loss (31% versus 8%)

Get in touch with Klinic to get access to the best Independent Practitioners that accept your insurance for comprehensive care, available 24/7/365

1 ottobre 2015;149:2628

There is a lot of debate on how to make these life-changing medicines accessible to patients who need them most, and its placing significant pressure on healthcare systems